Accelerate Your Antibody Discovery Program
At Invenra, we offer flexible and powerful solutions to meet your antibody discovery needs—whether you require rapid bispecific and monoclonal antibody discovery or a flexible scale, high-yield monoclonal or bispecific antibody expression for lead molecule development.
Rapid Discovery
Our new Rapid Bispecific Discovery Services or Rapid Monoclonal Discovery Services, powered by the B-Body® Bispecific Platform, deliver lead panels in just 2–4 months through functional screening of 250+ bispecific combinations from 90 parallel discovery screens.
Antibody Expression
Once lead panels are identified, you can seamlessly add antibody expression in multiple scale formats, enabling both high-throughput functional testing and large-scale preclinical studies with all the benefits of the high-yielding B-Body Platform.
Fast-track your therapeutic antibody development today—contact us to learn more!